HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emanuel Della-Torre Selected Research

Immunoglobulin G4-Related Disease

5/2024Increased prevalence of malignancies in patients with IgG4-related disease: implications for clinical care.
3/2024Fibrotic phenotype of IgG4-related disease.
12/2023Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
10/2023B-cell depletion with obinutuzumab for the treatment of IgG4-related disease.
3/2023B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
1/2023IgG4-related autoimmune liver disease.
5/2022Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.
1/2022Dupilumab as a potential steroid-sparing treatment for IgG4-related disease.
1/2022Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease.
10/2021Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emanuel Della-Torre Research Topics

Disease

36Immunoglobulin G4-Related Disease
05/2024 - 06/2014
18COVID-19
03/2023 - 01/2020
7Fibrosis (Cirrhosis)
03/2024 - 12/2015
5Autoimmune Pancreatitis
01/2024 - 01/2019
4Neoplasms (Cancer)
05/2024 - 01/2020
4Pneumonia (Pneumonitis)
10/2022 - 08/2020
4Inflammation (Inflammations)
10/2021 - 01/2016
4Meningitis
01/2018 - 11/2013
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 12/2015
3Hypersensitivity (Allergy)
01/2022 - 02/2017
2Lymphadenopathy
10/2021 - 01/2019
2Respiratory Insufficiency (Respiratory Failure)
04/2021 - 01/2021
2Osteoporosis
01/2021 - 01/2020
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
07/2017 - 08/2016
1Castleman Disease (Castleman's Disease)
01/2024
1Vasculitis (Vasculitides)
12/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2023
1Rheumatic Diseases (Rheumatism)
03/2023
1Disease Progression
09/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2022
1Myocarditis (Carditis)
09/2022
1Connective Tissue Diseases (Connective Tissue Disease)
05/2022
1Kimura Disease
01/2022
1Asthma (Bronchial Asthma)
10/2021
1Systemic Scleroderma (Systemic Sclerosis)
10/2021
1Hemorrhage
01/2021
1Multi-centric Castleman's Disease
01/2021
1Edema (Dropsy)
01/2021
1Thrombosis (Thrombus)
01/2021
1Fever (Fevers)
08/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2020

Drug/Important Bio-Agent (IBA)

20Immunoglobulin G (IgG)IBA
05/2024 - 01/2014
13GlucocorticoidsIBA
03/2024 - 06/2014
13Rituximab (Mabthera)FDA Link
03/2023 - 12/2015
7Interleukin-6 (Interleukin 6)IBA
12/2023 - 01/2020
7CytokinesIBA
05/2022 - 01/2016
7Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2014
6Interleukin-1 (Interleukin 1)IBA
12/2021 - 06/2020
4ColchicineFDA LinkGeneric
10/2022 - 01/2020
3sarilumabIBA
10/2022 - 10/2020
3Immunoglobulins (Immunoglobulin)IBA
05/2022 - 11/2013
3Immunoglobulin E (IgE)IBA
01/2022 - 01/2020
2SteroidsIBA
03/2023 - 01/2022
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2023 - 06/2014
2VaccinesIBA
09/2022 - 10/2021
2ChemokinesIBA
05/2022 - 01/2020
2AntibodiesIBA
12/2021 - 09/2014
2Prednisone (Sone)FDA LinkGeneric
10/2021 - 01/2020
2C-Reactive ProteinIBA
04/2021 - 06/2020
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021 - 06/2020
2tocilizumab (atlizumab)FDA Link
01/2021 - 01/2020
2InterleukinsIBA
01/2021 - 10/2020
2mavrilimumabIBA
11/2020 - 08/2020
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2020 - 07/2020
2Monoclonal AntibodiesIBA
08/2020 - 01/2020
2CollagenIBA
01/2020 - 12/2015
2Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 10/2015
2Granzymes (Granzyme)IBA
01/2018 - 01/2016
1siltuximabIBA
01/2024
1inebilizumabIBA
12/2023
1Ustekinumab (CNTO 1275)FDA Link
10/2023
1obinutuzumabIBA
10/2023
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
03/2023
1Antiviral Agents (Antivirals)IBA
03/2023
1TroponinIBA
09/2022
1Messenger RNA (mRNA)IBA
09/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1dupilumabIBA
01/2022
1ORALIT (ORS)IBA
01/2022
1Interleukin-13IBA
01/2022
1BNT162 VaccineIBA
10/2021
1Tyrosine (L-Tyrosine)FDA Link
10/2021
1c-Mer Tyrosine KinaseIBA
10/2021
1LigandsIBA
10/2021
1Protein SIBA
10/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2021
1Azathioprine (Imuran)FDA LinkGeneric
10/2021
1Interleukin-17 (Interleukin 17)IBA
10/2021
1OF 900IBA
04/2021
1Ferritins (Ferritin)IBA
04/2021
1Oxygen (Dioxygen)IBA
04/2021
1CT-P10IBA
02/2021
1Biosimilar PharmaceuticalsIBA
02/2021
1HemosiderinIBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2020
1Ritonavir (Norvir)FDA Link
06/2020
1LopinavirFDA Link
06/2020
1ApoferritinsIBA
06/2020
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2020

Therapy/Procedure

13Therapeutics
03/2024 - 11/2016
3Remission Induction
03/2023 - 01/2019
2Artificial Respiration (Mechanical Ventilation)
10/2022 - 08/2020
2Aftercare (After-Treatment)
01/2022 - 01/2018
1Lasers (Laser)
01/2024
1Drug Therapy (Chemotherapy)
09/2022
1Noninvasive Ventilation
06/2020